Abstract:OBJECTIVE:To analysis clinical phenotype and potential genetic cause of a family affected with hereditary coagulation factor Ⅻ deficiency.METHODS:The prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (FIB), D-Dimer (D-D), coagulation factor Ⅻ activity (FⅫ:C) and coagulation factor Ⅻ antigen (FⅫ:Ag) were determined for phenotype diagnosis of the proband and his family members(3 generations and 5 people). Targeted capture and whole exome sequencing were performed in peripheral blood sample of the proband. Possible disease-causing mutations of F12 gene were obtained and further confirmed by Sanger sequencing. The corresponding mutation sites of the family members were analyzed afterwards. The online bioinformatics software AutoPVS1 and Mutation Taster was used to predict the effects of mutation sites on protein function.RESULTS:The APTT of the proband was significantly prolonged, reaching 180.9s. FⅫ:C and FⅫ:Ag of the proband was significantly reduced to 0.8% and 4.17%, respectively. The results of whole exome sequencing displayed that there were compound heterozygous mutations in F12 gene of the proband, including the c.1261G＞T heterozygous nonsense mutation in exon 11 (causing p.Glu421*) and the c.251dupG heterozygous frameshift mutation in exon 4 (causing p.Trp85Metfs*53). Both mutations are loss of function mutations with very strong pathogenicity, leading to premature termination of the protein. AutoPVS1 and Mutation Taster software predicted both mutations as pathogenic mutations. The results of Sanger sequencing revealed that c.1261G＞T heterozygous mutation of the proband was inherited from his mother, for which his brother and his daughter were c.1261G＞T heterozygous carriers. Genotype-phenotype cosegregation was observed in this family.CONCLUSION:The c.1261G＞T heterozygous nonsense mutation in exon 11 and the c.251dupG heterozygous frameshift mutation in exon 4 of the F12 gene probably account for coagulation factor Ⅻ deficiency in this family. This study reports two novel pathogenic F12 mutations for the first time worldwide.

Hereditary Thrombotic Thrombocytopenic Purpura in a Chinese Boy With a Novel Compound Heterozygous Mutation of the ADAMTS13 Gene

[Identification of Two Novel Mutations in ADAMTS13 Gene in a Patient with Hereditary Thrombotic Thrombocytopenic Purpura].

[A Clinical Study of Congenital Thrombotic Thrombocytopenic Purpura].

Hereditary thrombotic thrombocytopenic purpura mimicking immune thrombocytopenia was revealed by miscarriage—novel compound heterozygous mutations in hTTP

Therapy of Hereditary Ttp with Adamts13 Deficiency - A Case Report and Review of the Literature.

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases

A 2-Day-old Neonate with Hyperbilirubinemia and Thrombocytopenia

A Novel TFG C.793c>g Mutation in a Chinese Pedigree with Charcot‐Marie‐Tooth Disease 2

Novel Homozygous Silent Mutation of ITGB3 Gene Caused Glanzmann Thrombasthenia

[Genetic Study and Prenatal Diagnosis of a Family with Thrombocytopenia-Absent Radius (TAR) Syndrome].

Novel ADAMTS13 Mutation in a Family with Three Recurrent Neonatal Deaths: a Case Report and Literature Review

[Analysis of A Pedigree with Hereditary Coagulation Factor Ⅻ Deficiency Caused by Compound Heterozygous Mutations].

Lethal Perinatal Hypophosphatasia Caused by a Novel Compound Heterozygous Mutation: a Case Report

Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura

ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura

Novel Compound Heterozygote Mutations of TJP2 in a Chinese Child with Progressive Cholestatic Liver Disease

Clinical Characteristics and Genetic Analysis of a Chinese Pedigree Affected with Tuberous Sclerosis Complex

Novel Compound Heterozygous TMPRSS15 Gene Variants Cause Enterokinase Deficiency

[A heterozygous point mutation G13328A in antithrombin gene causes thrombosis].

A Novel Heterozygous Point Mutation Causing Coagulation Factor XII Deficiency As the Molecular Mechanism of Fatal Thrombosis Event in a Chinese Pedigree.